$PCVX

$59.97 -$0.46 (0.76%) Close

$PCVX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$PCVX Management Team

Mr. Grant Pickering

Chief Executive Officer

Co-Founder

Director

Age 57

Compensation $39.64M USD

Sex Male

Mr. James Wassil

Executive Vice President

Chief Operating Officer

Age 55

Compensation $17.87M USD

Sex Male

Mr. Mikhail Eydelman

Senior Vice President

General Counsel

Chief Compliance Officer

Corporate Secretary

Age 44

Compensation $5.663M USD

Sex Male

Mr. Harp Dhaliwal

Company's Chief Technical Operations Officer

Age 51

Compensation $1.844M USD

Sex Male

Dr. Carlos Paya

Independent Chairman of the Board

Age 66

Compensation $525.0K USD

Sex Male

Mr. Andrew Guggenhime

President

Chief Financial Officer

Age 57

Compensation $17.88M USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Grant Pickering Chief Executive Officer Co-Founder Director	57	$39.64M USD	Male
Mr. James Wassil Executive Vice President Chief Operating Officer	55	$17.87M USD	Male
Mr. Mikhail Eydelman Senior Vice President General Counsel Chief Compliance Officer Corporate Secretary	44	$5.663M USD	Male
Mr. Harp Dhaliwal Company's Chief Technical Operations Officer	51	$1.844M USD	Male
Dr. Carlos Paya Independent Chairman of the Board	66	$525.0K USD	Male
Mr. Andrew Guggenhime President Chief Financial Officer	57	$17.88M USD	Male

Board of Directors

From the proxy statement filed Apr 23, 2026

Directors

serving now

Independent

8 of 9

stated in the proxy

Average tenure

5.3 years

from year joined

CEO also chairs the board

Carlos Paya

Director	Age	On board	Independent	Committees	Other public boards	Pay
Olivier Brandicourt	70	2025 1 year	Independent	None stated	Alnylam Pharmaceuticals, Inc.	Not stated
Halley Gilbert	56	2020 6 years	Independent	Audit Committee	Arcutis Biotherapeutics, Inc.	Not stated
Grant E. Pickering CEO	58	2013 13 years	Not independent	None stated	LeonaBio, Inc. (formerly Athira Pharma, Inc.)	Paid as CEO
Annie Drapeau	59	2021 5 years	Independent	None stated	None stated	Not stated
Teri Loxam	54	2021 5 years	Independent	None stated	None stated	Not stated
Carlos Paya Board chair	67	2021 5 years	Independent	None stated	Collegium Pharmaceutical, Inc.	Not stated
John Furey	61	2024 2 years	Independent	None stated	None stated	Not stated
Jacks Lee	62	2023 3 years	Independent	None stated	None stated	Not stated
Heath Lukatch	58	2018 8 years	Independent	None stated	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$PCVX Management Team

Mr. Grant Pickering

Mr. James Wassil

Mr. Mikhail Eydelman

Mr. Harp Dhaliwal

Dr. Carlos Paya

Mr. Andrew Guggenhime

Board of Directors

Related-party transactions

No related-party transactions disclosed